Enthea provides health insurance coverage for Psychedelic-Assisted Therapy (PAT).

We believe that employer-purchased health plans are essential for providing access to this new treatment to the greatest number of people.

Employer funding is the way the US healthcare system operates.

Enthea's Mission: Safe, affordable access to psychedelic healthcare for all who can benefit.

Ready to Launch

Enthea is poised to launch health plans for Ketamine-Assisted Therapy starting in January 2022.

Our initial customer is a recognized industry leader, based in California. They’ve already announced the new benefit to their employees and will be making a public announcement in January.

According to their CEO, they are “excited to be the first company in history to offer health plan coverage for psychedelic healthcare for our employees and their families.”

We Need Your Help

We can’t launch without funding. We need $2M to run these pilots and begin our nationwide rollout.

We are relying on the support of the people who want PAT to succeed – who believe in the power of this therapy, and who share our goal of equitable access to psychedelic healthcare.

Enthea provides health insurance coverage for Psychedelic-Assisted Therapy (PAT). We believe that employer-purchased health plans are essential for providing access to this new treatment to the greatest number of people. Employer funding is the way the US healthcare system operates.

Enthea's Mission: Safe, affordable access to psychedelic healthcare for all who can benefit.

Enthea provides health insurance coverage for Psychedelic-Assisted Therapy (PAT).

We believe that employer-purchased health plans are essential for providing access to this new treatment to the greatest number of people.

Employer funding is the way the US healthcare system operates.